Evidence map›Paper›PMID 36698148›Full record

ReviewItalian journal of pediatrics2023

Pediatric Gastroenterology and Hepatology in Italy before and after the COVID-19: Lessons learned and management changes by SIGENP.

Valeria Dipasquale, Marco Deganello Saccomani, Angelo Di Giorgio, Salvatore Oliva, Silvia Salvatore, Caterina Strisciuglio, Renato Tambucci, Paolo Lionetti, Claudio Romano

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Italian journal of pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Valeria DipasqualePediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.
Marco Deganello SaccomaniDepartment of Pediatrics, Woman's & Children's University Hospital of Verona, 37126, Verona, Italy. marco.deganello@gmail.com.
Angelo Di GiorgioPediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII, Bergamo, Italy.
Salvatore OlivaPediatric Gastroenterology and Liver Unit, Maternal and Child Health Department, Sapienza University of Rome, Rome, Italy.
Silvia SalvatoreDepartment of Pediatrics, "F. Del Ponte" Hospital, University of Insubria, Varese, Italy.
Caterina StrisciuglioDepartment of Woman, Child and General and Specialistic Surgery, University of Campania "Vanvitelli", Naples, Italy.
Renato TambucciDigestive Endoscopy Unit, Department of Gastroenterology, Hepatology and Nutrition, Bambino Gesù Children's Hospital, Rome, Italy.
Paolo LionettiDepartment NEUROFARBA, University of Florence, Gastroenterology and Nutrition Unit, Meyer Children's Hospital, Florence, Italy.
Claudio RomanoPediatric Gastroenterology and Cystic Fibrosis Unit, Department of Human Pathology in Adulthood and Childhood "G. Barresi", University of Messina, Messina, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Around the world, the 2019 Coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has raised serious public health problems and major medical challenges. The Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) published several papers on the impact of COVID-19 on the current management, diagnosis, and treatment of acute and chronic gastrointestinal, hepatic, immune-mediated, and functional disorders. The present article summarizes the most relevant SIGENP reports and consensus during and after the peak of the COVID-19 outbreak, including the diagnosis and treatment of inflammatory bowel disease (IBD), indications and timing of digestive endoscopy, and insights into the novel hepatitis.

Indexed as

COVID-19GastroenterologyInflammatory Bowel DiseasesLiver DiseasesChildHumansItalySARS-CoV-2Anti-TNF-αCOVID-19Digestive endoscopyHepatitisInflammatory bowel diseaseLiver diseasePediatricsSARS-CoV-2SIGENPTelemedicine

Identifiers

PMID36698148
PMCPMC9877500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.